BCM
NUS icon

Bayesian Capital Management’s Nu Skin NUS Stock Holding History

Bayesian Capital Management’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,402
Closed -$141K – 771
2025
Q1 		$141K Buy
+19,402
New +$141K 0.02% 522
2024
Q3 		– Sell
-16,600
Closed -$175K – 938
2024
Q2 		$175K Buy
+16,600
New +$210K 0.02% 618
2023
Q1 		– Sell
-6,437
Closed -$271K – 1002
2022
Q4 		$271K Buy
+6,437
New +$248K 0.04% 516
2019
Q4 		– Sell
-11,770
Closed -$501K – 702
2019
Q3 		$501K Buy
11,770
+6,000
+104% +$252K 0.09% 274
2019
Q2 		$285K Buy
+5,770
New +$293K 0.06% 370
2018
Q4 		– Sell
-3,568
Closed -$294K – 731
2018
Q3 		$294K Buy
+3,568
New +$284K 0.05% 464

Other funds holding NUS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bayesian Capital Management's NUS Position: Q2 2025 in Review

Bayesian Capital Management sold out of Nu Skin (NUS) in Q2 2025, closing a stake of 19,402 shares — an estimated $141K sold.

Bayesian Capital Management first reported a position in NUS in Q3 2018 and held it in 6 quarters. The position peaked at $501K in Q3 2019. 179 funds tracked by Wall St. Rank hold NUS as of Q2 2025.

  • Bayesian Capital Management reported no remaining Nu Skin position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 19,402 Nu Skin shares in Q2 2025, an estimated $141K.
  • Bayesian Capital Management first reported a position in Nu Skin in Q3 2018 and held it in 6 quarters.
  • Bayesian Capital Management's Nu Skin position peaked at $501K in Q3 2019.
  • 179 funds tracked by Wall St. Rank held Nu Skin as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.